Market Overview:
The global levonorgestrel API market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of unplanned pregnancies, rising awareness about contraception methods, and technological advancements in the field of contraception. Based on type, the global levonorgestrel API market can be segmented into short-acting contraceptive APIs and long-acting contraceptive APIs. The short-acting contraceptive APIs segment is expected to account for a larger share of the market than the long-acting contraceptive APIs segment during the forecast period. This can be attributed to their easy availability and low cost as compared to long-acting contraceptives. Based on application, the global levonorgestrel API market can be divided into levonorgestrel tablet products, mixture products (containing both progesterone and estrogen), and hormone-releasing IUDs (intrauterine devices). The hormone-releasing IUDs segment is anticipated to register higher growth during the forecast period owing to their high efficacy in preventing pregnancies as compared with other types of contraceptives.
Product Definition:
Levonorgestrel API is a synthetic progesterone hormone used as contraception. It is available in pill, implant, and injectable forms. Levonorgestrel is also used to treat endometriosis and abnormal uterine bleeding.
Short-Acting Contraceptive API:
Short-Acting Contraceptive API, also known as Sino-implant (II) or birth control pill is a man-made peptide hormone which prevents pregnancy. It works by binding to the estrogen and progesterone receptors in the target cells, leading to changes in the activity of genes involved in fertility.
Long-Acting Contraceptive API:
Long-acting contraceptive (LAC) is a drug or medication that prevents pregnancy for more than three years. The most common forms of long-acting birth control are Intrauterine Devices (IUDs) and Long-Acting Reversible Contraception (LARC). LARCs include subdermal implants, intrauterine pumps, and vaginal rings.
Application Insights:
levonorgestrel tablet was the most prominent application of the global levonorgestrel API market in 2017. The product is used for birth control and hormone replacement therapy among others. Rising awareness regarding health and wellness, growing population, and changing lifestyles are expected to drive demand over the forecast period.
Hormone-releasing IUD is anticipated to be one of the fastest-growing applications during the forecast period owing to increasing research on new methods of female reproductive health management, such as Copper T (CuT) IUDs that have been gaining popularity due to their low cost compared with other methods available in market. Levonorgestrel API also finds application in mixture products such as progesterone-only pessaries that are used for emergency contraception among other uses such as endometrial ablation procedures performed by gynecologists or obstetricians at hospitals or clinics. These factors are likely to create positive outlook for overall industry growth over next few years.
Regional Analysis:
North America dominated the global levonorgestrel API market in 2017. North America is a major hub for pharmaceutical and biotechnology companies, which are involved in R&D activities for new drug development. The presence of major players such as Pfizer Inc.; Merck & Co., Inc.; and AbbVie, Inc. has contributed to the dominance of this region.
Asia Pacific market was valued at USD X billion in 2017 owing to high unmet medical needs coupled with growing awareness regarding family planning initiatives taken by various governments across countries such as India; China; Japan; Indonesia etc.
Growth Factors:
- Increasing demand for birth control pills owing to changing lifestyle and growing awareness about contraception
- Rising prevalence of sexually transmitted infections (STIs) and other reproductive health issues
- Growing number of women in the workforce and their need for effective contraception methods
- Technological advancements in levonorgestrel API manufacturing process
- Rising popularity of long-acting reversible contraceptives (LARCs)
Scope Of The Report
Report Attributes
Report Details
Report Title
Levonorgestrel API Market Research Report
By Type
Short-Acting Contraceptive API, Long-Acting Contraceptive API
By Application
Levonorgestrel Tablet, Mixture Products, Hormone-releasing IUD
By Companies
Bayer HealthCare, Qinhuangdao Zizhu Pharmaceutical, Yangzhou Pharmaceutical, Lupin, Hubei Gedian Humanwell, Sterling Spa, Formos, Huazhong Pharm, ASG Biochem
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
137
Number of Tables & Figures
96
Customization Available
Yes, the report can be customized as per your need.
Global Levonorgestrel API Market Report Segments:
The global Levonorgestrel API market is segmented on the basis of:
Types
Short-Acting Contraceptive API, Long-Acting Contraceptive API
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Levonorgestrel Tablet, Mixture Products, Hormone-releasing IUD
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Bayer HealthCare
- Qinhuangdao Zizhu Pharmaceutical
- Yangzhou Pharmaceutical
- Lupin
- Hubei Gedian Humanwell
- Sterling Spa
- Formos
- Huazhong Pharm
- ASG Biochem
Highlights of The Levonorgestrel API Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Short-Acting Contraceptive API
- Long-Acting Contraceptive API
- By Application:
- Levonorgestrel Tablet
- Mixture Products
- Hormone-releasing IUD
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Levonorgestrel API Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Levonorgestrel API is a prescription drug used to prevent pregnancy. Levonorgestrel is a synthetic progesterone and is available as an oral pill, injection, or implant.
Some of the major companies in the levonorgestrel api market are Bayer HealthCare, Qinhuangdao Zizhu Pharmaceutical, Yangzhou Pharmaceutical, Lupin, Hubei Gedian Humanwell, Sterling Spa, Formos, Huazhong Pharm, ASG Biochem.
The levonorgestrel api market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Levonorgestrel API Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 Levonorgestrel API Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 Levonorgestrel API Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the Levonorgestrel API Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global Levonorgestrel API Market Size & Forecast, 2020-2028 4.5.1 Levonorgestrel API Market Size and Y-o-Y Growth 4.5.2 Levonorgestrel API Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Short-Acting Contraceptive API
5.2.2 Long-Acting Contraceptive API
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Levonorgestrel Tablet
6.2.2 Mixture Products
6.2.3 Hormone-releasing IUD
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Levonorgestrel API Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Levonorgestrel API Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Short-Acting Contraceptive API
9.6.2 Long-Acting Contraceptive API
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Levonorgestrel Tablet
9.10.2 Mixture Products
9.10.3 Hormone-releasing IUD
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Short-Acting Contraceptive API
10.6.2 Long-Acting Contraceptive API
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Levonorgestrel Tablet
10.10.2 Mixture Products
10.10.3 Hormone-releasing IUD
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Short-Acting Contraceptive API
11.6.2 Long-Acting Contraceptive API
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Levonorgestrel Tablet
11.10.2 Mixture Products
11.10.3 Hormone-releasing IUD
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Short-Acting Contraceptive API
12.6.2 Long-Acting Contraceptive API
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Levonorgestrel Tablet
12.10.2 Mixture Products
12.10.3 Hormone-releasing IUD
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Short-Acting Contraceptive API
13.6.2 Long-Acting Contraceptive API
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Levonorgestrel Tablet
13.10.2 Mixture Products
13.10.3 Hormone-releasing IUD
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Levonorgestrel API Market: Competitive Dashboard
14.2 Global Levonorgestrel API Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Bayer HealthCare
14.3.2 Qinhuangdao Zizhu Pharmaceutical
14.3.3 Yangzhou Pharmaceutical
14.3.4 Lupin
14.3.5 Hubei Gedian Humanwell
14.3.6 Sterling Spa
14.3.7 Formos
14.3.8 Huazhong Pharm
14.3.9 ASG Biochem